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A B S T R A C T
Little information exists on the occurrence and the ultimate fate of pharmaceuticals in the water bodies in India
despite being one of the world leaders in pharmaceutical production and consumption. This paper has reviewed
19 published reports of pharmaceutical occurrence in the aquatic environment in India [conventional activated
sludge wastewater treatment plants (WTPs), hospital WTPs, rivers, and groundwater]. Carbamazepine
(antipsychoactive), atenolol (antihypertensive), triclocarban and triclosan (antimicrobials), trimethoprim and
sulfamethoxazole (antibacterials), ibuprofen and acetaminophen (analgesics), and caffeine (stimulant) are the
most commonly detected at higher concentrations in Indian WTPs that treat predominantly the domestic sewage.
The concentration of ciprofloxacin, sulfamethoxazole, amoxicillin, norfloxacin, and ofloxacin in Indian WTPs
were up to 40 times higher than that in other countries in Europe, Australia, Asia, and North America. A very few
studies in Indian rivers reported the presence of ciprofloxacin, enoxacin, ketoprofen, erythromycin, naproxen,
ibuprofen, diclofenac and enrofloxacin. Similar compounds were reported in rivers in China, indicating a similar
usage pattern in both of these developing countries. In a study reported from an open well in southern India, the
groundwater showed the presence of cetirizine, ciprofloxacin, enoxacin, citalopram and terbinafine, which was
close to a WTP receiving effluents from pharmaceutical production.
1. Introduction
Pharmaceuticals and personal care products (PPCPs) include active
ingredients of prescription and non-prescription drugs for human and
veterinary use, disinfectants, illicit drugs, body lotions, etc. (Kaplan,
2013; Bu et al., 2013). The PPCPs thus consumed evoke a specific
biological response from the host, after which are ultimately discharged
into the environment. Hirsch et al. (1999) and Kummerer (2009) have
reported that ~10–90% of the administered dose of PPCPs are excreted
from the human body in their parent form, while the rest are excreted
as metabolites and/or conjugated forms. The excreted PPCPs reach the
wastewater treatment plants (WTPs) and finally discharge raw or
treated effluent into the groundwater, rivers, lakes, oceans, and soil
(Fig. 1). They have been detected in the aquatic environment since the
1970s (Veach and Bernot. 2011 and references therein), and in the last
twenty years, in all types of surface water, groundwater and the oceanic
environment (WHO, 2011; Klosterhaus et al., 2013; Luo et al., 2014). In
the aquatic environment, PPCPs can be toxic to certain aquatic
organisms and trigger antibiotic resistance amongst pathogens
(Behera et al., 2011; Kidd et al., 2007; Xiao et al., 2001; Kolpin et al.,
2002; Kristiansson et al., 2011). Nevertheless, limited literature exists
for establishing the effects of a cocktail of PPCP mixture in the
environment, on the aquatic biota and the humans (Tixier et al.,
2003; Daughton and Ternes, 1999).
India is among the top five producers of pharmaceutical chemicals,
with an expected turnover of USD 45 billion per year by 2020 (KPMG
International, 2006). The organized sector of Indian pharmaceuticals
consists of around 250–300 companies, with its drug exports growing
30% annually (KPMG International, 2006). In other words, every third
pill taken in the world is manufactured in India. Among the bulk
formulations, around 80% have been reported to be consumed indi-
genously (Kallummal and Bugalya, 2012). On the other hand, treatment
capacity of domestic sewage in India is far below the quantity of sewage
generated from 1.3 billion people; only 31% of the total sewage
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produced (∼38,254 million liters per day) in 908 cities were treated in
2008 (Subedi et al., 2015a).
Despite high rates of production and consumption of PPCPs across
the country and shortage in demand and supply for the sewage
treatment, limited literature is available to account for their occurrence,
transport, and fate in the aquatic environment (Subedi et al., 2015a;
Subedi et al., 2015b; Rehman et al., 2013; Mutiyar and Mittal, 2014).
This review provides an overview of levels of PPCP contamination in
Indian water bodies, which can potentially trigger more large-scale
nationwide studies on the occurrence of PPCPs and their ecological
impacts. The pharmaceutical residue levels in domestic wastewater,
hospital effluent, river water, and groundwater in India are compared
with that reported elsewhere. Finally, recommendations for an efficient
management of PPCP contamination in the aquatic environment, that
are important for the sustainable solution, are provided.
2. Pharmaceutical contaminants in India
2.1. Wastewater treatment plants
Twelve studies have reported the pharmaceuticals in wastewater
from conventional activated sludge treatment based WTPs in India
(Larsson et al., 2007; Fick et al., 2009; Mutiyar and Mittal, 2013a, 2014;
Singh et al., 2014; Akiba et al., 2015; Subedi et al., 2015a;
Prabhasankar et al., 2016; Archana et al., 2016; Mohapatra et al.,
2016; Anumol et al., 2016; Subedi et al., 2017) (Table 1).
WTP outlets are the primary point sources of pharmaceutical
contamination in the rivers and oceans (Daughton and Ternes, 1999).
The existing wastewater treatment processes are incapable of removing
most of the pharmaceutical contaminants; removal efficiencies typically
ranged from 12.5% to 100% (Santos et al., 2007; Luo et al., 2014). The
microbial transformation and/or deconjugation of glucuronides of the
select pharmaceuticals and their active metabolites can have negative
removal efficiency (Subedi et al., 2015a). Removal efficiency depends
on the treatment process, sludge age, the geography of the area, and the
rainfall rate (Chen et al., 2012). The overall pharmaceutical contam-
ination profile is also dependent on the pharmaceutical production and
usage pattern (Behera et al., 2011).
2.1.1. WTP receiving effluents from pharmaceutical industries
Despite of relatively lower levels (ng/L to µg/L) of pharmaceuticals
in wastewater from WTPs that process predominantly domestic sewage,
much higher concentrations (mg/L) of pharmaceutical contaminants
were reported from the WTPs that process wastewater from the
Fig. 1. Flow diagram of the PPCP pathways in the environment. WTPs: Wastewater
treatment plants, DWTPs: Drinking water treatment plants.
Table 1
Mean reported concentrations of pharmaceuticals and their metabolites in wastewater
(ng/L) from wastewater treatment plants (WTPs) in India.
Contaminants Influent Effluent
Antischizophrenics








Aripiprazole 44a, 29b, 4.20l, 14m, 71a, 0.4b
Dehydroaripiprazole 3.80k, 0.90l 2.20k
Sedatives-hypnotics-anxiolytics
Lorazepam 46a,26b, 23.6n, 19.8o 23a,12b, 19.1k, 27.4l,
24.4m, 8.26n, 41.8o
Alprazolam 41a, 10.1k, 4.20l, 6.98o 33a, 25b, 6.94k, 5.72l,
2.52o
α-hydroxyalprazolam 8.48k
Diazepam 23a, 25b, 6.80k, 4.46l,
6.66n, 196o
36a, 9.5b, 8.20k, 47.0l,
24.6n, 238o
Oxazepam 140a, 50b, 25.0m, 13.7o 85a, 50b, 38.2m,
17.0n, 17.0o
Nordiazepam 12a, 5.9b, 11.4k, 5.40l,
14.5m, 3.26n, 12.4o
85a, 50b, 10.5k, 6.70l,
8.56m, 3.08n, 5.96o
Carbamazepine 450a, 550b, 470d, 650e,
5800i, 8200j, 82.2k, 270l,
840m, 22.0n, 726o
580a, 480b, 88k, 236l,
900m, 147n, 318o
Antidepressants
Venlafaxine 38a, 5b, 30.6k, 10.3l, 138m,
9.30n, 46.2o
15a, 5b, 6.70k, 7.96l,
105m, 7.26n, 29.4o
Bupropion 19a, 23b 14a, 5b, 3.80k, 3.42o




Nosertraline 116k, 144l, 386m 55.6k, 57.6l, 50.0m
Citalopram 7.16l, 16.4n, 31.8o 9.46m, 14.7n, 29.8o
Antihypertensives
Propranolol 51a, 43b, 17.0k, 18.5l,
34.2m, 14.5n, 123o
43a, 28b, 7.98k, 11.8l,
37.6m, 11.4n, 12.3o







Diltiazem 55a, 16b, 5.64n, 1.39o 5a, 1.8b, 1.52m, 1.53o
Desacetyl diltiazem 32a, 6.40k, 1.04l, 7.62m,
1.55n, 44.4o
44a, 10b, 3.02k, 1.82l,
8.96m, 1.51n, 20.0o
Verapamil 36a, 25b, 1.74k, 0.74l,
0.61o
2a, 0.88l, 1.08m, 2.64o
Norverapamil 260a, 47b, 0.88k, 4.04m, 4a, 1.46m,
Antimicrobial









Trimethoprim 180a, 29b, 4010d, 210e, 3h,
4h, 23h, 33.0k, 90.8l, 156m,
160n, 35.6o
25b, 8h, 1h, 3h, 34.8k,
38.0l, 103m, 2080o
Sulfamethoxazole 220a, 100b, 3h, 66h, 195k,
288l, 552m, 414n, 2260o
260a, 25b, 13h, 27h,
9h, 70.2l, 318m, 228n,
296o
Ampicilin 104.2c 12.68c
Ciprofloxacin 20.06c, 12900f 8c, 11670f












(continued on next page)
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pharmaceuticals production facilities (Fick et al., 2009; Larsson et al.,
2007). Studies conducted at the PETL (Patancheru Enviro Tech Limited)
WTP near Hyderabad, that received 1.5 MLD effluents from ~90 bulk
drug manufacturers in the vicinity in Patancheru, found the highest
levels of pharmaceuticals ever reported in wastewater from elsewhere
in the world.
The maximum reported concentrations of ciprofloxacin in waste-
water were 0.6 µg/L across 6 WTPs in Canada (Guerra et al., 2014),
1.4 µg/L in Holland (Batt et al., 2007), 1.4 µg/L in Portugal (Santos
et al., 2013), 3.7 µg/L in Italy (Verlicchi et al., 2012), and 6.9 µg/L in
Australia (Pal et al., 2010). The concentration of ciprofloxacin reported
by Larsson et al. (2007) was ~4500 times higher than the next highest
reported (Australia). Ciprofloxacin is primarily prescribed for the
treatment of seasonal diseases such as bronchitis, pneumonia, sinusitis,
and is one of the most commonly prescribed drugs across the world
(Coutu et al., 2013). However, ciprofloxacin levels reported from a WTP
treating effluent from PETL may not represent an average level of
ciprofloxacin from Indian WTPs that treat predominantly the domestic
sewage. A revisit to the WTP after two years by Fick et al. (2009)
showed that the concentrations of all pharmaceuticals, except cetir-
izine, had reduced considerably (Table 2).
2.1.2. WTPs receiving domestic effluents in Northern India
Carbamazepine (a psychoactive), atenolol (antihypertensive), tri-
clocarban and triclosan (antimicrobials), trimethoprim and sulfa-
methoxazole (antibacterials), ibuprofen and acetaminophen (analge-
sics), and caffeine (stimulant) are the most commonly detected at
higher concentrations in wastewater from Indian WTPs that treat
predominantly the domestic sewage (Table 1). Mutiyar and Mittal
(2013a) studied the fate of amoxicillin in a domestic WTP (Vasantkunj)
that treats wastewater with an extended aeration technique in Delhi,
Table 1 (continued)
Contaminants Influent Effluent





Miconazole 67a, 42b, 23.4k, 65.6l,
1410m, 46n, 894o
8.0a, 25b, 17.8k, 8.92l,
1020m, 17.0o
Tiabendazole 64a, 123b 79a, 25b
Analgesics





Acetaminophen 9000a, 4500b, 11500f,
86800i, 7100j
690a, 340b
Ketoprofen 1080d, 200e, 39.6k, 52.2l,
9.80n
23.4k, 21.8l, 5.04o
Naproxen 120d, 59h, 43h, 58h 11h, 28h
Diclofenac 312d, 360e
Codeine 160a, 79b, 182k, 80.2l,
214m, 62.5n, 242o
82a, 25b, 44.2l, 208m,
37.2n, 38.0o
Oxycodone 4.0k, 21.6n
Mefenamic acid 1100a, 1100b 570a, 440b
Antihistamine
Diphenhydramine 97a, 44b, 83.0k, 34.8l,
112m, 144n, 130o
32a, 15b, 35.0k, 24.6l,
108m, 52.4n, 91.2o
DPMA 50.6n 32.0k, 23.2l, 25.4o
Ranitidine 1800i
Antiplatelet












Atorvastatin 410a, 380b 280a, 340b
UV-filter




Cocaine 32.4m, 17.0k, 55.6m,








Morphine 189k, 148m, 141o
EDDP 10.4l, 5.16m, 10.8l, 2.58n








MDA 440k, 59.2l, 216n, 98.0o 1150m, 114n
MDMA 23.0m 21.8k
Stimulant


















Acesulfame 57.6l, 72.8m, 62.4n, 85.4o 8.28k, 51.2l, 389m,
63.8n, 157o




NR: not-reported; pharmaceutical metabolites are italicized
DPMA: 2-(diphenylmethoxy) acetic acid; EDDP: (2-ethylidene-1,5-dimethy-3,3-diphenyl-
pyrrolidine); MDA: (3,4-methylenedioxyamphetamine); MDMA: (3,4-methylenedioxy-
methamphetamine).
a In Udupi WTP, Karnataka, inflow: 7.5 MLD, serve 150,000 people, anaerobic sludge
treatment, grab samples, sampled for consecutive seven days in a week (Subedi et al.,
2017)
b In Mangalore WTP, Karnataka, inflow: 12 MLD, serve 450,000 people, anaerobic
sludge treatment and upflow anaerobic sludge blanket digestor, grab samples, sampled
for consecutive seven days in a week (Subedi et al., 2017)
c In Okhla WTP, Delhi, inflow: 110 MLD, anaerobic sludge treatment, grab samples,
sampled for five days (Mutiyar and Mittal, 2014)
d In a WTP in Ghaziabad, Northern India, 24 h composite samples (from every 4-h grab
samples), sampled once (Singh et al., 2014)
e In a WTP in Lucknow, Utter Pradesh, 24 h composite samples (from every 4-h grab
samples), sampled once (Singh et al., 2014)
f In a WTP in Nagpur, inflow: 80 MLD, primary and secondary anaerobic sludge
treatment, grab samples, three sampling events in summer (Archana et al., 2016)
g In a WTP in Southern India, inflow: 1.7 MLD, serve ~15,000 people, anaerobic sludge
treatment, grab samples, a sampling event in each of three seasons (concentrations were
reported in the range) (Akiba et al., 2015)
h In a WTP in Southern India, inflow: 2.0 MLD, serve 9000 people, aeration sludge
treatment (cost-effective), grab samples, a sampling event in each of three seasons
(Prabhasankar et al., 2016)
i In a WTP in Western India, inflow: 46 MLD, facultative aerated lagoon based
treatment, 24 h composite samples, a sampling event in each of three seasons
(Mohapatra et al., 2016)
j In a WTP in Western India, inflow: 60 MLD, cyclic anaerobic sludge treatment, 24 h
composite samples, a sampling event in each of three seasons (Mohapatra et al., 2016)
k In Saidpur WTP in Bihar (Northern India), inflow: 19 MLD, serve 350,000 people,
anaerobic sludge treatment, grab samples, sampled once (Subedi et al., 2015a)
l In Beur WTP in Bihar (Northern India), inflow: 20.9 MLD, serve 275,000 people,
anaerobic sludge treatment, grab samples, sampled once (Subedi et al., 2015a)
m In Coimbatore WTP in Tamil Nadu (Southern India), inflow: 22.5 MLD, serve
350,000 people, anaerobic sludge treatment, grab samples, sampled once (Subedi et al.,
2015a)
n In Udupi WTP in Karnataka, inflow: 2.0 MLD, serve 10,000 people, anaerobic sludge
treatment, grab samples, sampled once (Subedi et al., 2015a)
o In Manipal WTP in Karnataka, inflow: 2.0 MLD, serve 12,000 people, anaerobic
sludge treatment, grab samples, sampled once (Subedi et al., 2015a)
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and found up to 172.6 ng/L in influent and 62.5 ng/L of amoxicillin at
the WTP outlet. Matsuo et al. (2011) found 100–2000 ng/L levels of
amoxicillin in a WTP that treats wastewater with an activated sludge-
based biological treatment process in Japan. However, amoxicillin was
not detected in wastewater from 96 WTPs involving the diverse
treatment processes including activated sludge and ozonation in a
European Union-wide monitoring survey (Loos et al., 2013). Mutiyar
and Mittal (2013a) attribute the higher concentration of amoxicillin in
the Vasantkunj WTP to that being sold as an over-the-counter drug in
India, whereas amoxicillin is a prescription antibiotic in Japan and
Europe. Other studies involving activated sludge in Australia reported
the similar concentration of amoxicillin in influent (Watkinson et al.,
2007), whereas 20 times higher concentration in wastewater effluent in
a WTP involving an advance biological treatment in Hong-Kong (Minh
et al., 2009). The removal efficiency of amoxicillin in WTPs varies
depending on the mass loading, type of treatment adopted, the size of
population served, their socio-economic status, and geographic location
(Spongberg and Witter, 2008).
Ciprofloxacin concentration in the outlet at Okhla WTP, Delhi
(Mutiyar and Mittal, 2014) is 2.5 times higher than that observed in
WTP outlets of Australia (Al-Rifai et al., 2007), 5 times higher than the
WTP outlets in Italy (Verlicchi et al., 2012) and at least 15 times higher
than the values in the WTP outlets of other countries given in Fig. 2.
The ciprofloxacin concentration in the discharge of Okhla WTP exceeds
the predicted no-effect concentration (PNEC=0.005 µg/L) (Deo and
Halden, 2013). Studies have shown that ciprofloxacin concentrations
ranging from 0.012 to 1.5 mg/L resulted in a decline in the genetic
diversity of algal communities (Wilson et al., 2003; Kaplan, 2013).
Therefore, further research is inevitable for the determination of
exposure levels of ciprofloxacin and relevant fluoroquinolones, and
their effects in the aquatic environment.
The concentration of one of the recalcitrant antihypertensives,
metoprolol, in Okhla WTP is approximately 4 times higher than in
wastewater effluents in Germany (Wick et al., 2009) and 8 times higher
than that detected in the USA. (Kostich et al., 2014). Typically,
metoprolol transformation/degradation ranges from 0–30% (Oulton
et al., 2010; Miege et al., 2009; Mutiyar and Mittal (2014) also found
the concentrations of ampicillin at 17.7 µg/L, gatifloxacin at 3.7 µg/L,
sparfloxacin at 0.5 µg/L and cefuroxime at 0.6 µg/L in the Okhla WTP
effluent.
Subedi et al. (2015a) reported 43 pharmaceuticals and their 13
metabolites including psychoactives, illicit drugs, and artificial sweet-
eners, in five WTPs that treat domestic sewage in India. The amphe-
tamine was measured at the mean concentration of 4.30 and 4.72 µg/L
in two WTPs, the highest ever reported concentration in wastewater.
Similarly, saccharin was the most abundant artificial sweetener with a
mean concentration of 303 µg/L in five WTPs (Subedi et al., 2015a).
Triclocarban (an antimicrobial), carbamazepine (antipsychoactive),
amphetamine (illicit drug), and saccharin (artificial sweetener) were
annually discharged at 2.55–252 kg from a WTP with an average flow
rate of 20.7 MLD and serving a population of 325,000 people in India.
2.1.3. WTPs receiving domestic effluents in Southern India
The concentration of ofloxacin found in a WTP outlet in Southern
India (Akiba et al., 2015) was about 3.2 times lower than in the
wastewater effluents from China (Bu et al., 2013) (Fig. 2). The
concentration of sulfamethoxazole in wastewater effluent from South
India were 0.23 µg/L (Subedi et al., 2015a), 0.63 µg/L (Akiba et al.,
2015) and 1.02 µg/L (Prabhasankar et al., 2016). The potential
sequential microbial transformation during anaerobic sludge treatment
in the WTPs studied by Subedi et al. (2015a) and Akiba et al. (2015)
may explain the lower concentration of sulfamethoxazole than in WTP
Table 2
Comparison of pharmaceutical concentrations in the PETL WTP during 2007 and 2009.
Year Pharmaceuticals concentrations (µg/L) References
CIP CET METP ENRO CIT NOR LOM ENO OFL
2007 31,000 1,400 950 900 840 420 300 300 160 Larsson et al. 2007
2009 14,000 2,100 4 210 430 25 8 ND 55 Fick et al. 2009
ND, not detected; CIP, ciprofloxacin; CET, cetirizine; METP, metoprolol; ENRO, enrofloxacin; CIT, citalopram; NOR, norfloxacin; LOM, lomefloxacin; ENO, enoxacin; OFL, ofloxacin
Fig. 2. Comparison of some commonly found pharmaceuticals in WTP effluents across the world. India (Mutiyar and Mittal, 2014; Akiba et al., 2015), Portugal (Santos et al., 2013), USA
(Kostich et al., 2014; Santos et al., 2010), Canada (Brun et al., 2006; Guerra et al., 2014); Australia (Al-Rifai et al., 2007), Italy (Verlicchi et al., 2012), and China (Bu et al., 2013).
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studied by Prabhasankar et al. (2016) that treats wastewater with an
aeration sludge treatment (cost-effective and less labour-intensive
wastewater treatment technique). The average concentration of sulfa-
methoxazole in the above WTPs were similar to the concentrations
obtained in a WTP outlet in NW Spain (Carballa et al., 2004), while 2.7
times lower than the average for Europe and Canada (1.7 µg/L for
Europe; Loos et al., 2013 and 1.8 µg/L for Canada; Guerra et al., 2014).
However, the concentration of SMX in the Indian WTP effluent was two
to four times higher than the WTP effluent in South Korea (Behera
et al., 2011) and a WTP in Ohio, USA (Spongberg and Witter, 2008).
Subedi et al. (2017) compared the mass loading and environmental
discharge of select psychoactives, antihypertensives, and antibiotics in
two WTPs in Southern India with that in wastewater from WTPs in the
USA. The mass loading (mg/d/1000 people) and environmental
discharge (mg/d/1000 people) of most of the studied pharmaceuticals
in the USA were found higher than in India, which may indicate the
different usage pattern of drugs.
2.1.4. WTPs receiving hospital effluents
Hospital effluents also act as point sources of pharmaceutical
pollution in the water bodies. Concentrations of pharmaceuticals in
hospital effluents are generally higher than in the domestic WTP
effluents (Kovalova et al., 2013). Two studies have reported the
concentrations of pharmaceuticals in hospital effluents in India
(Diwan et al., 2009, 2010; Akiba et al., 2015). Diwan et al. (2009,
2010) carried out a study on antibiotics in the effluents of two hospitals
in Ujjain (central India): the Ujjain Charitable Trust Hospital (UCTH)
and Chandrikaben Rashmikant Gardi Hospital (CRGH). Effluents from
UCTH contained 73 µg/L of ofloxacin, 81 µg/L of levofloxacin and
60 µg/l of ceftriaxone. Effluents from CRGH contained 237 µg/L of
ciprofloxacin, 88 µg/L of tinidazole, 81 µg/L of sulfamethoxazole and
23 µg/L of norfloxacin. Metronidazole was found at lower concentra-
tion (3.8 µg/L), while amoxicillin and erythromycin were not detected
in either of the hospital effluents. Akiba et al. (2015) analyzed waste-
water from two WTPs in Southern India that received the hospital
effluents; the first WTP exclusively treating hospital wastewater and the
second WTP treating both, hospital effluents and domestic sewage. The
WTP that received both the hospital and domestic effluents had higher
concentrations of SMX (13 times), trimethoprim (6 times) and ofloxacin
(5 times) in its outlet than the WTP that received only hospital
effluents. Studies carried out by Santos et al. (2013) on hospital
effluents in Coimbra (Portugal) showed values similar to those in
South India. Verlicchi et al. (2012) studied the effluents from two
hospitals in Italy, which were compared with the hospital effluents in
India and Portugal (Fig. 3). It is evident from the figure that
ciprofloxacin in the hospital effluent in India is about 10 times higher
than in Italy and five times higher than in Portugal. The concentration
of sulfamethoxazole is also about ten times higher than the correspond-
ing concentrations in Italy and Portugal, while that of ofloxacin is found
to be almost two times that in Italy and Portugal. However, the WTP in
Portugal shows a higher concentration of metronidazole and erythro-
mycin than in India and Italy. Doxycycline was found in similar
concentrations in hospital effluents from India and Italy. The large
difference in the concentrations of pharmaceuticals between the
effluents in these countries could be attributed to the functioning of
the treatment process, the consumption patterns, the population, and
the method of disposal of expired pharmaceutical compounds. The
comparison could have limitations based on the time of sample
collection and the type of samples, the treatment capacity of the plant
and the differing compositions of the hospital effluent between these
countries.
2.2. Rivers and Lakes
Sewage originating from the WTPs is the major source of pharma-
ceuticals in natural water bodies, followed by agricultural discharge
and direct discharge (Li et al., 2014). Eight studies have been carried
out on the pharmaceutical concentrations in Indian rivers (Fick et al.,
2009; Kristiansson et al., 2011; Mutiyar and Mittal, 2014; Ramaswamy
et al., 2011; Shanmugam et al., 2013; Iyanee et al., 2013; Archana et al.,
2016; Subedi et al., 2015a). All the studies have confirmed the presence
of pharmaceuticals in the concerned rivers. The effluents from PETL
discharge into the Isakavagu-Nakkavagu streams, which eventually
flow into the Godavari River. Pharmaceuticals in the river or lake
adsorb onto the soil/sediments, dilute, and undergo biological and/or
photochemical transformations (Onesios et al., 2008). The pharmaceu-
tical concentrations were significantly decreased when measured 30 km
downstream of the PETL as compared to that at the PETL outlet:
metoprolol (4 times), ofloxacin (9 times), cetirizine (22 times),
citalopram (86 times), ciprofloxacin (1400 times), and enrofloxacin
(3281 times) (Fick et al., 2009; Kristiansson et al., 2011). Subedi et al.
(2015a) reported 35 pharmaceuticals and 10 metabolites in open
sewage channels in residential areas. The Cooum River that flows
through the Chennai metropolitan city (population: 8.9 million) found
to be contaminated with triclocarban (6.18 µg/L), ibuprofen (2.32 µg/
L), a metabolite of antiplatelet carboxylic acid (1.37 µg/L), atenolol
(3.18 µg/L), and amphetamine (0.984 µg/L) (Subedi et al., 2015a).
Although there is a reduction of more than 95% in their concentra-
tion in the rivers, traces of these pharmaceuticals and their transforma-
tion products continue to remain in the water bodies, leading to subtle,
but long-term, changes in the aquatic environment (Long et al., 2013).
Mutiyar and Mittal (2014) found ampicillin, ciprofloxacin, gatifloxacin,
sparfloxacin and cefuroxime in the Yamuna River at 13.8 μg/L, 1.4 μg/
L, 0.48 μg/L, 2.1 μg/L and 1.7 μg/L, respectively. This is ~1000 times
Fig. 3. Comparison of PPCPs in hospital effluents in India (Diwan et al., 2009), Portugal (Santos et al., 2013) and Italy (Verlicchi et al., 2012). Abbreviations: CIP, ciprofloxacin; SMX,
sulfamethoxazole; NOR, norfloxacin; OFL, ofloxacin; MET, metronidazole; ERY, erythromycin; DXY, doxycycline.
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lower than the concentration of pharmaceuticals in the Isakavagu-
Nakkavagu stream samples collected downstream of PETL. Ramaswamy
et al. (2011) detected 13.0 ng/L of carbamazepine in the Kaveri River
and 139 ng/L of triclosan in the Bhavani River, a tributary of Kaveri.
Shanmugam et al. (2013) observed the presence of NSAIDs including
naproxen, diclofenac, ibuprofen, ketoprofen, and acetylsalicylic acid up
to 0.66 μg/L in the Kaveri, Vellar, and Tamiraparani Rivers. Iyanee
et al. (2013) observed seasonal variation in the concentration of
sulfamethoxazole (monsoon: 0.9 μg/L and post-monsoon: 0.16 μg/L)
in the Kaveri and Vrishabhavathi (a tributary of Kaveri) Rivers in India.
They suggested that the high levels of sulfamethoxazole during the
monsoon could be associated with the high amount of runoff from
agricultural lands in the surrounding areas.
In addition to erythromycin, chloramphenicol, and trimethoprim,
multidrug-resistant pathogenic bacteria were found in the Byramangala
tank, fed by the Vrishabavathi River, which resists multiple antibiotics
prescribed and consumed in India (Iyanee et al., 2013). Kristiansson
et al. (2011) detected very high levels of several classes of resistant
genes and elements of horizontal gene transfer (integrons, transposons,
and plasmids) in a river sediment in India, that received effluents from
a WTP serving ~90 drug production units near Hyderabad.
Concentrations of pharmaceuticals determined in rivers in India
were compared with those in China, that are equally stressed owing to
the comparable anthropogenic impact and their status, as the fastest
rising economies in the third world (Fig. 4). Based on the recent reports
on pharmaceutical residues in rivers from China (Bu et al., 2013; Zou
et al., 2011) and India (Shanmugam et al., 2013; Iyanee et al., 2013;
Fick et al., 2009), ciprofloxacin, enoxacin, gatifloxacin, and ketoprofen
levels in the water bodies in India are much higher than those in China.
This can reflect the different drug consumption patterns in India and
China; for example, 64% of Indians purchase pharmaceuticals without a
prescription, solely based on peer suggestions and prior experiences
(Mutiyar and Mittal, 2013b). China's water bodies, on the other hand,
have higher concentrations of erythromycin, naproxen, ibuprofen,
diclofenac and enrofloxacin. This could be due to the differences in
the health issues and climatic conditions between the two countries.
The concentrations of sulfamethoxazole and ofloxacin exhibit similar
patterns in the rivers in India and China. Metoprolol was observed in
Ishkavagu and Nakavagu rivers in three of the 5 sampling locations
both upsteam and downstream of the PETL discharge outlet. Their
presence could be from domestic sewage (upstream) and PETL (down-
stream) in the river.
2.3. Groundwater
A considerable amount of data exists on pharmaceutical wastes in
surface water; yet, literature demonstrating the pharmaceutical con-
tamination of groundwater is relatively less (Wolf et al., 2012; Stuart
et al., 2012). Fewer studies of pharmaceutical contamination in
groundwater might have been resulted from the analytical challenges
associated with the detection of the lower level of pharmaceutical
contaminants in matrix-complex ground water than in surface water.
Direct pathways of pharmaceutical contamination to the groundwater
include disposal of sewage effluents on land, sewer leakage, landfill
leachates, and sewage overflow during monsoon (Jones et al., 2002).
Moreover, land-use activities such as agriculture can surrogate the
presence of pharmaceuticals in groundwater (Fram and Belitz, 2011). In
India, groundwater accounts for over 65% of irrigation and 85% of
drinking water supplies (Globalwaterforum, 2012). However, only one
study reported pharmaceuticals in groundwater in India (Fick et al.,
2009). The wells around the PETL site have found to contain antibiotics
(ciprofloxacin, trimethoprim, enoxacin, ofloxacin, norfloxacin), cetir-
izine, citalopram, and terbinafine ranging from 0.021 µg/L to 28 µg/L.
A nationwide survey of antibiotics in groundwater in China found
0.019–1.27 µg/L of antibiotics (Ma et al., 2015). Overall, the maximum
concentration of ciprofloxacin in ground water from India (Fick et al.,
2009) was 90 and 43 times higher than in China (Ma et al., 2015) and
Spain (Cabeza et al., 2012), respectively. Schaider et al. (2016) found
27 organic waste contaminants including antibiotics, psychoactives,
analgesics, and antihypercholesterolemics upto 62 ng/L in 20 domestic
wells from Cape Cod, Massachusetts, USA.
There is a shortage of supply and demand for the centralized sewage
treatment in India, with ~30% of the sewage produced is treated by
municipal WTPs (Subedi et al., 2015a, Subedi et al., 2017). Therefore,
the majority of Indian households primarily rely on the on-site septic
systems for the treatment of domestic sewage or directly discharge
through straight-pipes into the surface/ground water and soil. The
pharmaceutical contaminants can percolate/infiltrate through the
vadose region and potentially contaminate the underlying groundwater
and nearby surface water (Subedi et al., 2015b; Verstraeten et al.,
2005). Therefore, it is critical to comprehend the fate of pharmaceutical
contaminants from septic systems and the associated ecological pro-
blems, particularly in developing countries where the majority of the
population is served by septic systems.
2.4. Recommendations
Most of the WTPs around the world are not designed for the
complete removal of pharmaceutical contaminants because the extent
of the ecological threats posed by PPCPs are vaguely understood (Luo
et al., 2014). Owing to their occurrence at trace levels in the aquatic
environment and a dearth of evidence of adverse effects on aquatic
ecosystem and humans, pharmaceuticals are generally not considered a
primary ecological threat, particularly in the developing countries such
as India.
Most of the studies on pharmaceutical residues in wastewater from
Indian WTPs are focussed on parent drugs; however, select metabolites
of drugs are discharged at higher concentration into the environment
than their parent analogues, and are physiologically active as their
parent drugs (Subedi et al., 2014, 2015a). Therefore, it is important to
include drug metabolites as target analytes to comprehend the overall
residual levels and their effects in the environment. It is important to
note that most of the fate studies of pharmaceuticals in Indian WTPs
involve grab samples (Table 1 footnotes), that may result into the over
or under-estimation of actual mass loads and environmental emission of
drugs. Therefore, 24 h composite wastewater samples for at least a
week-long sampling event in different seasons may provide authorities
the overall accurate levels of residual drugs in the environment.
Analytically, most of the fate studies of residual drugs in Indian WTPs
Fig. 4. Comparison of PPCP concentrations in Indian rivers (Fick et al., 2009; Mutiyar and
Mittal, 2014; Shanmugam et al., 2013; Iyanee et al., 2013) and Chinese rivers (Bu et al.,
2013). CIP: ciprofloxacin, ENO: enoxacin, ENR: enrofloxacin, OFL: ofloxacin, MET:
metoprolol, GAT: gatifloxacin, NAP: naproxen, DIC: diclofenac, IBU: ibuprofen, KET:
ketoprofen, SMX: sulfamethoxazole, ERY: erythromycin.
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have utilized external standard or internal standard method of quanti-
fication in wastewater, which is one of the most complex environmental
matrices. Isotopic dilution and matrix-match method of quantification
would provide more accurate and reproducible recoveries among fate
studies across different WTPs. Moreover, the pharmaceuticals are found
to accumulate in biological tissues in the aquatic ecosystem (Subedi
et al.; 2012). More studies on bioaccumulation of drugs residues and
their effect in indigenous aquatic organisms would provide significant
information to authorities to scheme guidelines and proper implication.
Large-scale studies, therefore, are required in local and state strata
to investigate the sources, overall fate, and the effects of pharmaceu-
tical contaminants on the flora and fauna. Temporal studies may
provide the subtle changes caused by these pharmaceuticals in the
aquatic environment. Therefore, the research networks and capacity
build-up among government and private institutions is important for
the establishment of a robust analytical protocol. Ample research
investment and the research fund are required to develop state-of-art
analytical capacity, enhance public awareness on the proper use of
used/unused drugs, and expand and update the conventional WTPs. In
addition, regulatory agencies are important to define and implement
proper guidelines on the maximum permissible limits for discharge into
the aquatic environment from production facilities, hospitals, and
municipal WTPs. Overall, a sustainable solution, one of the most
important challenges of 21st century, could somehow address the
pharmaceutical contamination and their effect in wildlife and humans.
3. Conclusion
Very few studies are reported on pharmaceutical contamination in
water bodies in India despite it being one of the largest drug producers
and consumers in the world. The environmental emission of pharma-
ceutical residues into the environment can be an imminent threat to the
water resources in India. Wide-range of pharmaceutical residues
derived from domestic use, hospitals, production facilities are reported
in wastewater, rivers, and groundwater including psychoactives, anti-
biotics, analgesics, antihistamine, illicit drugs, and artificial sweeteners.
Antibiotics (such as ciprofloxacin) in WTP receiving effluent from drug
production as well as amphetamine (illicit drug) from a WTP treating
domestic sewer are the highest ever reported from anywhere in the
world. Domestic WTPs in India revealed that the concentrations of
amoxicillin, ciprofloxacin, metoprolol and ofloxacin in the treated
effluents were higher than in WTPs in Europe, Japan, and Australia.
However, sulfamethoxazole from Indian WTPs is reported at similar
levels as in Spain but lower than in Europe and Canada. The over-the-
counter availability of wide-range of drugs in India could have resulted
in the higher levels of drug residues in the environment in addition to a
shortage of supply and demand of sewer treatment capacity, inefficient
treatment, as well as the lack of treatment regulations and implications.
Very few studies on pharmaceutical residues in rivers (only seven
studies in Yamuna, Kaveri, Vellar, Tamiraparani, Vrishabavathi,
Godavari, and Cooum River) and only one study in open wells
(groundwater) are reported. No study is reported on drug residues in
septic discharge despite > 50% of Indian population is being served by
on-site septic treatment systems. Overall, very few studies have
reported the mass loading and environmental discharge incorporating
pharmaceutical metabolites. There are no reports of pharmaceuticals in
indigenous aquatic organisms to understand bioaccumulation and
potential acute and chronic toxicity. This review provides the status
of understanding on pharmaceutical residues in the aquatic ecosystem
in India. This review provides important information for the stake-
holders including regulatory agencies in India to establish the minimum
permissible limits of pharmaceuticals in wastewater and spur research
on cost-effective pharmaceutical removal strategies in the Indian WTPs.
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